Malcolm Weir
Directeur Général chez Heptares Therapeutics Ltd.
Profil
Malcolm Weir is the founder and currently holds the position of Chairman & Chief Executive Officer at Heptares Therapeutics Ltd., a company he founded in 2007.
He is also currently serving as Chairman at Heptares Therapeutics Zurich AG since 2018 and as Director at The Biochemical Society since 2017.
In the past, Malcolm held the position of Director & Chief Scientific Officer at Galapagos Biotech Ltd.
from 2000 to 2013.
He was also the Head-Molecular Sciences Division at Glaxo Wellcome Plc.
Additionally, he served as an Advisor at Biological Sciences Research Council in 2011 and as a Principal at Lifearc.
From 2015 to 2020, Malcolm was the Executive VP, Chief Research & Development Officer at Sosei Group Corp.
Malcolm's education includes undergraduate and doctorate degrees from Imperial College London.
Postes actifs de Malcolm Weir
| Sociétés | Poste | Début |
|---|---|---|
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Directeur Général | 01/01/2007 |
The Biochemical Society
 The Biochemical Society Miscellaneous Commercial ServicesCommercial Services The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators. | Directeur/Membre du Conseil | 20/07/2017 |
Heptares Therapeutics Zurich AG
 Heptares Therapeutics Zurich AG Pharmaceuticals: MajorHealth Technology Part of Nxera Pharma Co., Ltd., Heptares Therapeutics Zurich AG is a private company that provides drug discovery and development services. Heptares Therapeutics Zurich AG is based in Zurich, Switzerland. | Président | 01/04/2018 |
Anciens postes connus de Malcolm Weir
| Sociétés | Poste | Fin |
|---|---|---|
Biological Sciences Research Council
 Biological Sciences Research Council Investment Banks/BrokersFinance The Biological Sciences Research Council operates as a funding agency for academic research and training in the biosciences arena. The private company is based in Swindon, UK and has subsidiaries in United Kingdom. | Corporate Officer/Principal | 01/01/2011 |
| NXERA PHARMA CO., LTD. | Directeur Technique/Scientifique/R&D | 25/03/2020 |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
| Glaxo Wellcome Plc | Corporate Officer/Principal | - |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Directeur Général | - |
Formation de Malcolm Weir
| Imperial College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NXERA PHARMA CO., LTD. | Health Technology |
| Entreprise privées | 7 |
|---|---|
| Glaxo Wellcome Plc | Health Technology |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Biological Sciences Research Council
Biological Sciences Research Council Investment Banks/BrokersFinance The Biological Sciences Research Council operates as a funding agency for academic research and training in the biosciences arena. The private company is based in Swindon, UK and has subsidiaries in United Kingdom. | Finance |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Commercial Services |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
The Biochemical Society
The Biochemical Society Miscellaneous Commercial ServicesCommercial Services The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators. | Commercial Services |
Heptares Therapeutics Zurich AG
Heptares Therapeutics Zurich AG Pharmaceuticals: MajorHealth Technology Part of Nxera Pharma Co., Ltd., Heptares Therapeutics Zurich AG is a private company that provides drug discovery and development services. Heptares Therapeutics Zurich AG is based in Zurich, Switzerland. | Health Technology |
